Online cognitive assessment for monitoring brain health
Official title: Longitudinal Cognitive Assessment by BoCA
Run by Alzheimer's Light LLC · NCT04114994 · Data updated 2026-11-12
This study is testing an online brain health test for people aged 50 and older to see if it can help track their thinking skills and identify any issues early on.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Alzheimer's Light LLC Industry-sponsored |
| Locations | 1 site (Miami, Florida) |
| Status | Recruiting |
| Started | October 1, 2019 |
| Main results expected | October 1, 2029 |
| Study ends | October 1, 2029 |
| Registry record updated | August 1, 2024 |
| Trial ID | NCT04114994 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this assessment are individuals aged 50 and older who are concerned about their cognitive health.
✕Probably not a fit
Patients younger than 50 years may not benefit from this assessment as it is specifically designed for older adults.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Boston Cognitive Assessment (BoCA) is an online, self-administered test designed for ongoing cognitive monitoring in individuals aged 50 and older. It features random, non-repeating tasks across eight cognitive domains to minimize learning effects and provide accurate assessments of cognitive performance. The test generates immediate feedback on domain scores and overall cognitive health, helping healthcare providers identify potential underlying conditions affecting cognition. By leveraging digital technology, BoCA aims to improve access to cognitive testing and support better treatment outcomes.
Why it matters
Potential benefit: If successful, this assessment could lead to earlier detection and intervention for cognitive decline, improving patient outcomes.
How similar studies have gone: Other studies utilizing digital cognitive assessments have shown promise in improving monitoring and treatment outcomes, indicating a favorable outlook for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: age 50 or older Exclusion Criteria: younger than 50 years
Where it's running
-
Andrey Vyshedskiy
Miami, Florida, United States Recruiting
Study contacts
- Study coordinator: ANDREY VYSHEDSKIY, Ph.D.
- Email: vysha@bu.edu
- Phone: 6174338577
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting disease progression in dementia using biomarkers and modeling
This study is trying to create a tool that helps predict how dementia will progress in people with mild cognitive impairment and different types of dementia, like Alzheimer's and Lewy Body Disease, by looking at brain scans, body fluids, and mental tests.
-
Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes
This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.
-
Biobank for studying ALS and Alzheimer's diseases
This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.